Therapeutic strategies for non-small cell lung cancer: Experimental models and emerging biomarkers to monitor drug efficacies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic strategies for non-small cell lung cancer: Experimental models and emerging biomarkers to monitor drug efficacies

Published:2023-02 Issue: Volume:242 Page:108347
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Bourreau Clara,Treps Lucas,Faure Sébastien,Fradin Delphine,Clere Nicolas

Funder

European Regional Development Fund

Ligue Contre le Cancer

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference207 articles.

1. A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC);Abuhelwa;Cancer Treatment Reviews,2022

2. Tissue-agnostic activity of BRAF plus MEK inhibitor in BRAF V600-mutant tumors;Adashek;Molecular Cancer Therapeutics,2022

3. FDA approval summary: pembrolizumab, atezolizumab, and cemiplimab-rwlc as single agents for first-line treatment of advanced/metastatic PD-L1-High NSCLC;Akinboro;Clinical Cancer Research,2022

4. Single cell mass cytometry of non-small cell lung cancer cells reveals complexity of in vivo and three-dimensional models over the petri-dish;Alföldi;Cells,2019

5. The lung microenvironment: an important regulator of tumour growth and metastasis;Altorki;Nature Reviews. Cancer,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for enhancing non-small cell lung cancer treatment: Integrating Chinese herbal medicines with epidermal growth factor receptor-tyrosine kinase inhibitors therapy;European Journal of Pharmacology;2024-10

2. Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study;Signal Transduction and Targeted Therapy;2024-06-14

3. Advances in genetic profile and therapeutic strategy of pulmonary large cell neuroendocrine carcinoma;Frontiers in Medicine;2024-02-27

4. Rutin Linoleate Triggers Oxidative Stress-Mediated Cytoplasmic Vacuolation in Non-Small Cell Lung Cancer Cells;Life;2024-02-01

5. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma;Journal of Experimental & Clinical Cancer Research;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3